New dementia numbers don't add up
If you want to know why Big Pharma is itching to get its dementia drugs approved, just take a look at the latest numbers: A third of all seniors supposedly die with the disease.
Not OF the disease, mind you. Just WITH the disease.
What's the distinction? Glad you asked -- because it's a distinction worth billions of dollars.
Hit a certain age, and you probably won't be as sharp as you used to be. That's not dementia, just Father Time doing what he does. In addition, most seniors take meds that cause memory loss and confusion.
But since most docs don't know which is caused by what, they're all told they "might" have dementia. The word "might" is lost in translation -- and from that moment on, they're dementia patients whether they actually have the disease or not.
So how's that worth billions?
Well, as I just told you, the next phase of dementia drugs is aimed at people with the earliest stages of the disease. That includes all those millions who "might" have dementia, but in reality don't.
And all of them will be expected to take these new meds for the rest of their lives.
All of them... but not YOU. You have me, and I've got two steps you can take right now to help turn your "might" into a "definitely not!"
First, work with a naturopathic doc to get off any med with brain-robbing side effects (no small order; that's most of the drugs taken by seniors).
Second, load up on the B vitamins that have been shown to protect the brain, keep dementia away, and stop or even reverse the disease if you do have it.
Douglass Report readers got the full story on that in the September 2012 issue, including the exact doses used in a promising clinical trial.
Not a subscriber? Not a problem -- sign up today, and you'll get complete access to all my back issues in my online archives.